Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Capital Markets Day

30th Nov 2021 07:00

RNS Number : 9573T
Ideagen PLC
30 November 2021
 

30 November 2021

 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

 

Capital Markets Day

 

A clear path to £200m ARR

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, will today host a Capital Markets Day for analysts and investors. Attendance at the event in person, hosted at the offices of finnCap, 1 Bartholomew Close, London, is invite-only. There will also be a live webcast which can be accessed from 14:00 GMT.

 

Any investors who wish to join the event virtually should register here: https://webcast.openbriefing.com/ideagen-21/

 

Today's presentation will be led by the Group's Chief Executive Officer, Ben Dorks, with insights from the Group's executive leadership team.

 

The presentation will cover the Group's bold ambitions and new targets for the next three years:

 

- the Group aims to become a global leader in a $30bn GRC market opportunity and targets pro-forma annual recurring revenue of £200m by April 2025;

 

- set out the financial and non-financial metrics that underpin this objective, including reflecting on the Group's achievements to date in building current pro-forma* revenue of £97m (run-rate ARR of £86m) and adjusted pro-forma EBITDA of £32m*; and

 

- the Group's M&A track record and the pathway established for executing and integrating; and

 

- the areas and routes to market for driving targeted 15% year-on-year organic growth.

 

Commenting on the event, Ben Dorks, Chief Executive Officer, said:

 

"Today we will set out how the Group will deliver on the significant opportunity that we see now and in the future.

 

Ideagen remains committed to becoming a global leader in the GRC market. Our purpose is to make complying with regulation easy, quick, and cost effective, and ensure we have a suite of world-class software products to enable that.

 

12 years of profitable growth, underpinned by our talented team and strong working culture, give us confidence that we can accelerate our growth and achieve the target £200m ARR by April 2025. We look forward to building on our achievements to date and delivering against our ambitious medium-term targets".

 

Copies of the presentation and a replay of the webcast will be available on the Group's website http://investors.ideagen.com following the event.

* adjusted EBITDA for the Group based on proforma revenues at the current EBITDA margin including the annualised impact of cost synergies that have already been recognised or are contracted

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

Enquiries:

Ideagen plc

01629 699 100

Ben Dorks, Chief Executive Officer

 

Emma Hayes, Chief Financial Officer

 

 

finnCap Limited

020 7220 0500

Henrik Persson / James Thompson (Nomad)

 

Alice Lane (ECM)

 

 

 

Canaccord Genuity Limited

020 7523 8000

Simon Bridges

 

Georgina McCooke 

 

Numis Securities Limited

Simon Willis

Joshua Hughes

 

020 7260 1000

FTI Consulting

020 3727 1000

Jamie Ricketts

[email protected]

Dwight Burden

Valerija Cymbal

 

About Ideagen plc

Ideagen's software helps companies comply with regulation and manage risk.

Ideagen is a leader in the +$30 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance. Ideagen has made 24 acquisitions since admission to AIM to build its market leadership.

More than 7,500 customers use Ideagen's software, including nine of the top 10 UK accounting firms, 7 of the top global aerospace and defence companies and 75% of leading pharmaceutical firms.

Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, BAE, Aggreko, US Navy, Bank of New York and Johnson Matthey, as well as 250 hospitals across the UK and US.

Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, EU, US, South East Asia and Australia. For further information please visit www.ideagen.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLBTTMTATTRB

Related Shares:

IDEA.L
FTSE 100 Latest
Value8,275.66
Change0.00